Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...
A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...
Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...
Nelmastobart (hSTC810) combined with capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A phase 1b clinical trial.
Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II or III colorectal cancer (JCOG2310A): An integrated analysis of three phase III randomized controlled trials. This ...
“Despite considerable progress in the HR positive, HER2 negative metastatic breast cancer treatment landscape, new therapies are still needed to tackle the frequent and complex challenge of disease ...
HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease. TROPION-Breast01 is a global, randomised, multicentre ...
High blood pressure affects multiple organs. Not only can hypertension add stress to the heart and damage arteries, leading to heart disease, but it also can cause strokes and kidney disease as ...
Treatment with pembrolizumab and fulvestrant provided disease control in half of patients with estrogen receptor (ER)-positive, HER2-negative, metastatic breast cancer in a phase 2 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback